Member Info for neilrich3

DHSC entered into a contract with Novacyt for the purchase of instruments and tests, it was the height of the pandemic and the DHSC was under immense pressure to increase their capacity for testing. At the end of 2020/early 2021 the DHSC changed their mind, performed a u-turn, in my opinion, many parts of the NHS did not have the resources to accurately perform POC testing, therefore these tests and instruments had been stockpiled in certain areas. DHSC suggested that the tests were not fit for purpose and asked for their money back. Q1 Novacyt now supplied PROMATE, which was outside of the contract and was being used successfully within the NHS, unfortunately DHSC decided to withhold payment pending their requested refund, Novacyt offered to replace product under warranty as per the contract, the dispute was born!!

Vindictive is not a word that I would use.

Although upon LinkedIn Novacyt report that they are now a Distributor for the Clonit, to visit the website for the full range and further information, yet I visit the Novacyt Website and can find no reference to Clonit. I have been able to locate some PCR tests for STI, although they appear to be the RUO under the GENESIG brand.

Disappointing, has the person posting upon Linkedin attempted to navigate the Novacyt website? Not easy!

Come on Novacyt...must do better!!

Top of the agenda should be a new CEO, someone to drive the business forward, clearly the interim CEO isn't capable. We are approaching 3 months since the departure of DA, therefore hopefully some news soon about his replacement.

I'd bet that both would come back to Novacyt, what with £100m in the bank, both likely to be invested personally. What do we think?

https://www.linkedin.com/posts/laura-sanz-s%C3%A1nchez-phd-20b2001b_ecogen-microgen-pathflowstrepa-activity-7011620482252713984-enLR?utm_source=share&utm_medium=member_desktop

Lets hope so, although I wonder whether we have the capacity to respond and how quick? We've be stung before with stock having to be written off, can't imagine they shall make that mistake again.

'A large amount of stock, which had previously been provided for, was written off and disposed of during late 2021, with the cost being charged to 'Cost of inventories recognised as an expense' and a corresponding release of the stock provision being made.'

The company should issue an RNS stating that they know no reason for the sudden rise in the share price and that materially nothing has changed.

Perhaps they should close the company down for Christmas more often, or maybe they could take a longer break, does wonderful things for the share price.

Should COVID be making a comeback, although I'm sure it never went away, surly the UKHSA/DHSC shall be forced to purchase testing products from their own CTDA Register.

31% up....unfortunately there is no leak...just another pump before the dump!

https://twitter.com/Nantanreikan/status/1608101498659176450

Shame that Novacyt is closed for business until 3 Jan 2023, that does not make sense either.

Eurofins Technologies is rebranded to Gold Standard Diagnostics as of the 1st of December, 2022.
This brand was already established for our clinical product line a few years ago, and we are extending now the Gold Standard Diagnostics branding to our entire test kit, reagent and instrument development, and manufacturing business. This includes Food&Feed Safety, Environmental&Water Testing and Animal Health, and of course the Clinical line.
We are becoming one strong and unified team, under the same name and branding, across businesses, regions and applications. We trust that this change will simplify and improve customer experience, and support us to be an innovative and trusted solution provider for all our stakeholders.

Eurofins has been rebranded, yet they are holding on to the Microgen brand which they appear to have acquired? Nothing makes sense.

https://www.linkedin.com/posts/matthewmayhew_weekly-influenza-update-week-48-december-activity-7008389802836250624-s5H5?utm_source=share&utm_medium=member_desktop

Would be better if we had a PCR test for Step A surly, perhaps with us being a first responder it might be in the works.

https://www.linkedin.com/posts/clonit-srl_our-new-facility-activity-7004519519385731072-LGOL?utm_source=share&utm_medium=member_desktop

Q32 @ 1:10

An interesting comment from Graham Mullis :)

https://www.linkedin.com/posts/antonio-argenio-1aab7b22_unicef-diagnostics-rdt-activity-7003322910207533057-qc1p?utm_source=share&utm_medium=member_desktop

They made reference to STI within the full year results 28/04/2022:
Beyond these initial areas of unmet need that we have prioritised, we are evaluating additional areas to develop solutions in areas such as STI, UTI, hospital acquired infections, sepsis and meningitis/encephalitis. The Company will provide more insight on these additional areas as it executes against the initial priorities outlined in this plan.

WBAFC, I doubt it is that simple, selling within China that is, stick to your day job ;)

Interesting...
https://www.iprep.xyz